Cargando…
Nintedanib induces senolytic effect via STAT3 inhibition
Selective removal of senescent cells, or senolytic therapy, has been proposed to be a potent strategy for overcoming age-related diseases and even for reversing aging. We found that nintedanib, a tyrosine kinase inhibitor, selectively induced the death of primary human dermal fibroblasts undergoing...
Autores principales: | Cho, Hyun-Ji, Hwang, Jeong-A, Yang, Eun Jae, Kim, Eok-Cheon, Kim, Jae-Ryong, Kim, Sung Young, Kim, Young Zoon, Park, Sang Chul, Lee, Young-Sam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440251/ https://www.ncbi.nlm.nih.gov/pubmed/36055997 http://dx.doi.org/10.1038/s41419-022-05207-8 |
Ejemplares similares
-
Identification of SYK inhibitor, R406 as a novel senolytic agent
por: Cho, Hyun-Ji, et al.
Publicado: (2020) -
Senotherapeutics: emerging strategy for healthy aging and age-related disease
por: Kim, Eok-Cheon, et al.
Publicado: (2019) -
Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
por: Lim, Songhyun, et al.
Publicado: (2021) -
Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects
por: Kim, Jae-Yong, et al.
Publicado: (2017) -
Co-inhibition of ATM and ROCK synergistically improves cell proliferation in replicative senescence by activating FOXM1 and E2F1
por: Yang, Eun Jae, et al.
Publicado: (2022)